Found 6 matching trials
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
PHASE1Diarrhoea caused by Shigella (shigellosis) is of major public health import...
Location
KEMRI-Wellcome Trust Research Programme
A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults
PHASE2The purpose of this study is to evaluate the efficacy, safety and immunogen...
Location
GSK Investigational Site
Controlled Human Infection Model Challenge/Rechallenge
PHASE1The goal of this study is to better understand Shigella immunity. The study...
Location
Center for Immunization Research (CIR) at Johns Hopkins School of Public Health (JHSPH)
Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate
PHASE1This study is an inpatient trial to determine the safety, immunogenicity an...
Location
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University
Phase 2 Shigella Vaccine and Challenge
PHASE2This is a trial to evaluate the safety, reactogenicity, immunogenicity and ...
Location
The Hope Clinic of Emory University
Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain
PHASE1Development of an S. sonnei human challenge model using a newly manufacture...
Location
Cincinnati Children's Hospital Medical Center